Fouad Namouni, PRESIDENT, R & D at Blueprint Medicines Corp (BPMC), sold 12,978 shares at $88.80 ($1.2M) on 2025-03-05, disclosed to the SEC on 2025-03-07.
Seasonal sale ($1.2M) by PRESIDENT, R & D — this insider has traded BPMC in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $88.80 | 6,489 | $576K | 50.0% |
| 2 | $88.80 | 6,489 | $576K | 50.0% |
| Total | $88.80 avg | 12,978 | $1.2M | 100% |
| Filing → |
| BPMC | SELL | 2023-10-05 | $362K | — | Filing → |
| BPMC | SELL | 2023-03-08 | $175K | — | Filing → |
| BPMC | SELL | 2022-10-05 | $468K | — | Filing → |